Madeed raises $925K pre-seed for AI preventive healthcare in Saudi Arabia
What's the deal? Madeed, a Saudi healthtech startup building an AI-powered preventive healthcare platform, has closed a $925K pre-seed round. The company uses advanced biomarkers, lab testing, and artificial intelligence to detect early disease risk indicators before symptoms appear.
The round included SEEDRA Ventures, Unity Investment Partners, and Seen Growth, alongside earlier investors Vision Ventures and several Saudi angel investors. Vision Ventures had led an initial $400K tranche in January.
Founded in 2025 by Adam Bataineh, Madeed says it is the first platform of its kind in the Middle East focused on personalised preventive healthcare and longevity. The funding will go toward product development and expanding clinical and lab partnerships, starting in Saudi Arabia.
Why now? Saudi Arabia's healthcare sector is undergoing rapid transformation under Vision 2030, with the kingdom investing heavily in digital health infrastructure and preventive care. Madeed attracted 150 subscribers during its pilot phase — a signal the founders see as validating demand ahead of a broader launch.
"We dedicated the past period to conducting the necessary operational tests on the platform to ensure its efficiency, smooth operation, and the integration of the services offered," said Bataineh. "We are optimistic about the results achieved so far."
What could go wrong? Preventive healthcare platforms face steep challenges in driving sustained consumer engagement. Convincing healthy people to pay for early risk detection — before they feel symptoms — requires significant behavioural change and trust in AI-driven health recommendations.
The Saudi market also has a growing number of healthtech startups competing for the same pool of early adopters and institutional partnerships.
The signal: Madeed's raise reflects growing investor appetite for healthtech in the Gulf, particularly platforms that combine AI with proactive, data-driven care. As healthcare systems worldwide shift from treatment to prevention, the Middle East is emerging as a testing ground for startups tackling that transition — backed by government reform agendas and a young, digitally native population.
Read more: wamda.com
